Biomedicines (Dec 2023)

SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic Strategies

  • Na Li,
  • Xiaodan Li,
  • Yifu Ding,
  • Xiao Liu,
  • Karin Diggle,
  • Tatiana Kisseleva,
  • David A. Brenner

DOI
https://doi.org/10.3390/biomedicines11123280
Journal volume & issue
Vol. 11, no. 12
p. 3280

Abstract

Read online

Sterol regulatory element-binding proteins (SREBPs) are master transcription factors that play a crucial role in regulating genes involved in the biogenesis of cholesterol, fatty acids, and triglycerides. As such, they are implicated in several serious liver diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma (HCC). SREBPs are subject to regulation by multiple cofactors and critical signaling pathways, making them an important target for therapeutic interventions. In this review, we first introduce the structure and activation of SREBPs, before focusing on their function in liver disease. We examine the mechanisms by which SREBPs regulate lipogenesis, explore how alterations in these processes are associated with liver disease, and evaluate potential therapeutic strategies using small molecules, natural products, or herb extracts that target these pathways. Through this analysis, we provide new insights into the versatility and multitargets of SREBPs as factors in the modulation of different physiological stages of liver disease, highlighting their potential targets for therapeutic treatment.

Keywords